Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Brim Biotechnology Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, which means the pending work is divided between separate examination assignments.
HELLMAN, KRISTINA M is the busiest examiner, with 1 pending matter. Practitioners should assess each record independently and avoid inferring a uniform prosecution position from the shared technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELLMAN, KRISTINA M | 1 | 65.1% | +55.5% |
| REYNOLDS, FRED H | 1 | 33.2% | +39.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562810 | COMPOSITION COMPRISING PEDF-DERIVED SHORT PEPTIDE, PREPARATION METHOD THEREOF, AND USE THEREOF | HELLMAN, KRISTINA M | — |
| 17766250 | COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND USES THEREOF | REYNOLDS, FRED H | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18562810 | COMPOSITION COMPRISING PEDF-DERIVED SHORT PEPTIDE, PREPARATION METHOD THEREOF, AND USE THEREOF | HELLMAN, KRISTINA M | 1654 | §103§112DP | Non-Final OA | — | Pending | Nov 20, 2023 |
| 17766250 | COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND USES THEREOF | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | — | Pending | Apr 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBrim Biotechnology Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Kristina M Hellman has the most, with 1 of Brim Biotechnology Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.